{"id":"W2296942186","doi":"10.1200/jco.2015.33.18_suppl.lba502","title":"PALOMA3: A double-blind, phase III trial of fulvestrant with or without palbociclib in pre- and post-menopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer that progressed on prior endocrine therapy.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Fulvestrant; Palbociclib; Medicine; Metastatic breast cancer; Internal medicine; Goserelin; Clinical endpoint; Oncology; Breast cancer; Interim analysis; Tolerability; Cancer; Gynecology; Tamoxifen; Clinical trial; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001981651,0.0003945146,0.002861761,0.0002401523,0.00003775841,0.00001767143,0.000185759,0.0001715049,0.00007843775],"category_scores_gemma":[0.0002387027,0.0002050737,0.00008488177,0.0003547134,0.0007828978,0.0003336707,0.0000344641,0.001088794,8.1218e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004034968,"about_ca_system_score_gemma":0.003907904,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001841959,"about_ca_topic_score_gemma":0.0003325442,"domain_scores_codex":[0.9957074,0.0006184732,0.00192642,0.0004193924,0.0008372167,0.0004911132],"domain_scores_gemma":[0.9940129,0.001326507,0.00272316,0.000253421,0.0009862756,0.000697761],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8186631,0.007367932,0.005742907,0.00004063818,0.001742079,0.0006571252,0.003098764,0.00002239071,0.001536369,0.000008522107,0.00001224568,0.1611079],"study_design_scores_gemma":[0.6615074,0.2837803,0.04871036,0.0005600611,0.0003890049,0.001431762,0.001904762,0.0000102131,0.0008728873,0.00004688563,0.000572781,0.000213602],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914206,0.0007872256,0.00005910977,0.004960224,0.0002104589,0.002425034,0.00005452728,0.00001521389,0.00006763446],"genre_scores_gemma":[0.9923375,0.001314963,0.004834241,0.0006063688,0.0005061004,0.0002338175,0.000005044696,0.00005953512,0.000102459],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2764124,"threshold_uncertainty_score":0.8362661,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1249024538445055,"score_gpt":0.4693961585716095,"score_spread":0.344493704727104,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}